Ambulatory blood pressure (BP) measurement (ABPM) is recommended to assess optimal BP control, we studied its influence after an acute type B aortic dissection (ATBAD).
Acute type B aortic dissection (ATBAD) is a rare but potential life-threatening vascular emergency and a complex disease to manage. Recent European guidelines state that endovascular techniques are the first line strategy in cases with complications [1] . ATBAD often occurs in patients presenting with the association of atherosclerosis and an old and poorly controlled hypertension [2] . Current guidelines on hypertension management recommend the use of ambulatory blood pressure (BP) measurement (ABPM) [3] . Since, ABPM is a better predictor of cardiovascular outcome than office BP [4] . In this retrospective, single center study, we assessed the prevalence and the impact of ABPM in the chronic phase of type B aortic dissection, as this important aspect is still unknown.
Method
We retrospectively collected data of all patients admitted for a first ATBAD between January 2004 and September 2014 to cardiology intensive care unit. The acute nature of the aortic syndrome was defined by the onset of symptoms < 14 days to diagnosis. Penetrating aortic ulcer and iatrogenic or traumatic dissection were excluded from the study. Pre-hospital and in-hospital deaths were also excluded to assess only patients with a reasonable follow-up.
At admission, the BP target to reach was 120/70 mmHg as recommended by the European guidelines of 2001 [5] . In cases with evidence of impending rupture or end-organ ischemia endovascular management was favoured. Ranging from aortic fenestration (scissor technique) to aortic stent graft implantation and/or visceral (renal, celiac, superior mesenteric arteries) stenting [6] [7] . Malperfusion syndrome presented as bowel, renal and/or lower limb clinical acute ischemia. Blood investigations at admission and the day of discharge were incorporated into the statistical analysis.
The casual BP on the day of discharge was recorded. Then a 24 hours-ABPM (90207 monitor Spacelabs Healthcare, Snoqualmie, WA, USA) was performed. The cuff was placed on the right arm if the patient had an aortic stentgraft coveraging of the left subclavian artery.
Daytime BP was defined between 6:00 am and 10:00 pm. "Dipper" status was defined as the presence of decreases in the BP values of more than 10% (compared with daytime values).
Clinical BP was recorded at the time of the BP monitoring placement, and use of the various classes of antihypertensive medications taken at the time of the ABPM. A medication score (defined as the total number of antihypertensive medications taken by a patient) was recorded.
The BP target to reach in the chronic phase was 135/80 mmHg at each consultation [1] .
All patients underwent Computed Tomography angiogram (CTA) imaging from the apex of the lungs to the femoral heads before discharge. CTA analysis was performed on a dedicated 3D workstation (Aquarius, Terarecon, CA, USA). The true and false lumen diameters were measured at the level of the left pulmonary artery perpendicular to the line passing through the two insertion points of the intimal flap [8] . Left ventricular ejection fraction was estimated with Simpson's rules. Left ventricle mass was measured according the American Society of Echocardiography and normalized against body surface area and against height 1.7 [9] . Overall survival and aortic event-free probabilities were estimated using the Kaplan-Meier method, and between-group comparisons were done using the log-rank test. Under random censoring assumption, loss of follow-up were censored at last follow-up; for aortic event-free probabilities, patients died from non-aortic disease were also treated as censored events at time of death. As recommended, the duration shown on the curves was stopped if less than 10% of the patients were still under follow-up [10] . Association of 24-BP values with allcause mortality and aortic events were assessed in univariable Cox models; results are reported as hazard ratio (HR) and predictive power was evaluated using the harrell's c statistic. If a significant association was established, a threshold value to best predict aortic event-free probabilities was determined using the algorithm of maximization of hazard ratio.
Statistical testing was done at the two-tailed a level of 0.05 and data were analyzed using the SAS software package, release 9.4 (SAS Institute, Cary, NC).
Results
One hundred and fifty-three consecutive patients with first ATBAD were identified from hospital records. In-hospital mortality was 11% (n=17). Twenty five patients have no useful blood pressure monitoring data. Finally, our analysis on 111 patients with ABPM available for follow-up. The left ventricular ejection fraction was significantly higher in the BP controlled group (60% ± 5.9 vs 58% ± 5.1, p=0.0447). Demographics data and the cardiovascular risk factors are described in Table 1 .
The median delay between discharge and ABPM measurement was 2[0.3-4] months with no difference between the 2 groups. The average treatment score was 3.9 ± 1.4 drugs per day with no difference between groups. The average clinical BP in all patients at discharge was controlled (128.8 mmHg ± 15.9 for the systolic, and 73.4 mmHg ± 12.5 for the diastolic). The systolic BP at discharge was significantly higher in the uncontrolled group compared with the controlled group (133 mmHg +/-13.9 vs 126.3 mmHg ± 16.5, p=0.036). The clinical BP at the time of ABPM was 131.1±18.8 mmHg for the systolic and 76.3±11.5 mmHg for the diastolic.
The details of the ABPM data are listed in Table 2 .
The acute phase medical management is summarized in (Table 4) Overall all-cause mortality at follow-up was 21% (n=22) with a median delay of 41 months. There was no significant association between the different BP data (BP at discharge, BP at consultation time, and all data of the ABPM) and the risk of death during follow-up.
Discussion
Night time systolic BP is associated with an increased risk of aortic events during follow-up.
The results show that endovascular revascularization of (visceral/renal) malperfusion syndrom is a strong predictor of BP control.
As guidelines are targeting a low normal BP, we could have demonstrated earlier that 4.3 drugs are necessary to reach the target BP [11] . The European Society of Hypertension define BP control as a mean BP of less than 130/80mmHg on the 24 hours ABPM. The ABPM thresholds were determined using the results of outcome studies such as the International Database of Ambulatory blood pressure in relation to Cardiovascular Outcome (IDACO), as the Ohasama study, as the PAMELA study and as the Dublin study [12-13-14-15] . The threshold of 130/80 mmHg on ABPM corresponds to a BP threshold of 140/90 mmHg at consultation. In the management of chronic aortic syndrome, the European Society of Cardiology suggests a threshold of 135/80mmHg on office measurement [5] . Thus, the ideal target to reach with ABPM should be lower.
Complications in the acute phase were recently defined by an expert consensus as malperfusion, hypertension associated with malperfusion or persisting despite full medical therapy, or increase in peri-aortic hematoma and hemorrhagic pleural effusion suggesting impending rupture [16] . In the special situation of resistant hypertension, early endovascular treatment has to be discussed. Indeed, data from IRAD suggest increased adverse outcomes in the acute phase for patients with resistant hypertension resulting in an increase in mortality mostly due to aortic rupture [17] . About 20 to 25% of individuals with ATBAS have a malperfusion syndrome with 10 to 15% of these involving renal arteries, which is an independent predictor of in-hospital mortality [18] . Renal malperfusion can be difficult to diagnose and can be underestimated [19] . Data from a series of spontaneous renal artery dissections presenting with severe hypertension report clinical success in treating hypertension by endovascular stent placement during long term follow-up [20] . The present M A N U S C R I P T
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8 study cohort suggests a potential benefit of early endovascular treatment of malperfusion on successful blood pressure control in the chronic phase. Coagulation disorders have previously been described in the acute phase of aortic dissection and been shown to affect prognosis [21] [22] . Our study also suggests a relationship between platelet count and blood pressure control which could be explained by chronic inflammation induced by the dissection and false lumen activity, such conceptual thoughts however need more solid foundation.
Finally, nighttime systolic BP appears to have a particularly important prognostic significance. Previous data suggest that night time systolic BP was the best predictor of cardiovascular events and mortality in patients with hypertension [12-13-23] . A higher systolic BP probably results from greater sympathetic activity [24] or greater stiffness of the peripheral arterial system. Considering the results, it is also logical to speculate that similar finding can be observed in type A dissection patient.
The limitations of this study include its retrospective design and single center data source, rendering it difficult to generalise our findings.
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